FDA's Post-Market NME Safety Reviews "Useful," But May Not Continue
This article was originally published in The Pink Sheet Daily
Executive Summary
Evaluations lead to labeling changes but were resource-intensive, according to agency's final report on a pilot program involving five NMEs.